GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models
Robert J. Torphy(University of North Carolina at Chapel Hill), Yuwen Zhu(University of Colorado Anschutz Medical Campus)
Cited by 41
Related Papers
The GPR171 pathway suppresses T cell activation and limits antitumor immunity
|Nature Communications|2021|31
Circulating CD8 <sup>+</sup> mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patients
|Clinical & Translational Immunology|2022|26